Brief
18,000 LAGC Biologics commits half of Yokohama’s mammalian capacity before the site opens
An undisclosed biopharma has booked half of the mammalian capacity at AGC Biologics' Yokohama site: five products, 35+ batches a year, four PPQ campaigns in two years.
